Sio Capital Management, LLC Intra Cellular Therapies, Inc. Transaction History
Sio Capital Management, LLC
- $268 Million
- Q4 2024
A detailed history of Sio Capital Management, LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Sio Capital Management, LLC holds 1,946,800 shares of ITCI stock, worth $249 Million. This represents 15.91% of its overall portfolio holdings.
Number of Shares
1,946,800Holding current value
$249 Million% of portfolio
15.91%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ITCI
# of Institutions
415Shares Held
88.5MCall Options Held
284KPut Options Held
105K-
Vanguard Group Inc Valley Forge, PA9.72MShares$1.24 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$809 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY5.13MShares$656 Million0.03% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.25MShares$416 Million1.36% of portfolio
-
Norges Bank Oslo, Q83.21MShares$411 Million0.04% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $12.1B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...